 MENLO PARK, Calif. and BOSTON, Nov. 06, 2020 GLOBE NEWSWIRE -- Adicet Bio, Inc. Nasdaq: ACET, a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that company management will participate in upcoming virtual investor conferences and events in November and December. 